488 results on '"Linszen, D."'
Search Results
2. Towards Horizon 2020: challenges and advances for clinical mental health research – outcome of an expert survey
3. Prediction of psychosis in clinical high-risk patients by the Schizotypal Personality Questionnaire. Results of the EPOS project
4. Physical illnesses, developmental risk factors and psychiatric diagnoses among subjects at risk of psychosis
5. Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders
6. Motivational interviewing and interaction skills training for parents of young adults with recent-onset schizophrenia and co-occurring cannabis use: 15-month follow-up
7. Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial
8. Psychosis in epilepsy patients and other chronic medically ill patients and the role of cerebral pathology in the onset of psychosis: A clinical epidemiological study
9. Pathways to psychosis: A comparison of the pervasive developmental disorder subtype Multiple Complex Developmental Disorder and the “At Risk Mental State”
10. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia: An open label study
11. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale
12. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia: A [123I]-IDEX SPECT study
13. The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis
14. Component structure of the Positive And Negative Syndrome Scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders
15. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender
16. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial
17. Detection of people at risk of developing a first psychosis: comparison of two recruitment strategies
18. Ethnicity and baseline symptomatology in patients with an At Risk Mental State for psychosis
19. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
20. 17 Psychotische stoornissen
21. Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis
22. Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis
23. Neurophysiological paradigms in patients at ultra high risk for developing psychosis
24. ERP components before and after transition to a first psychotic episode
25. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?
26. Course of psychopathology in at-risk mental states of psychosis - what happens to the non-converters?
27. Reported quality of life in patients at high risk of psychosis
28. The clinical course of patients at-risk for developing psychosis
29. Duration of untreated psychosis and ethnicity
30. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia
31. Negative symptoms in patients at-risk of psychosis and their association with transition to psychosis
32. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?
33. Catecholamines in adults with 22q11 deletion syndrome
34. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls
35. White-matter markers for psychosis in a prospective ultra-high-risk cohort
36. Increased saccadic rate during smooth pursuit eye movements in patients at Ultra High Risk for developing a psychosis
37. Dopaminergic modulation of human reward system: a placebo controlled dopamine depletion fMRI study
38. Early intervention in patients at ultra high risk of psychosis: benefits and risks
39. Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography
40. Age at onset of cannabis use is associated with age at onset of high risk symptoms for psychosis: OR107
41. Appraisals of Expressed Emotion from significant others by young people at high-risk of developing psychosis — results from the European Prediction of Schizophrenia (EPOS) study: OR095
42. Perceived negative attitude from other as an early sign of psychosis: OR099
43. The impact of childhood trauma on psychosis — evidence from the EPOS/RADEP ultra-high risk study: OR059
44. A clinical multivariate model for the prediction of psychosis — results from EPOS: OR062
45. Antisaccade deficit is present in young first-episode patients with schizophrenia but not in their healthy young siblings
46. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia
47. Effects of a functional COMT polymorphism on brain anatomy and cognitive function in adults with velo-cardio-facial syndrome
48. Failure to Find P50 Suppression Deficits in Young First-Episode Patients With Schizophrenia and Clinically Unaffected Siblings
49. Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E)
50. Adolescence, schizophrenia and drug abuse: a window of vulnerability
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.